PROCEPT BioRobotics Corporation (PRCT) Tops Q2 EPS by 1c

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q2 EPS of ($0.56), $0.01 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $33.1 million versus the consensus estimate of $30.31 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Brokers expand AI trading tools as automated agents gain traction
• JPMorgan Upgrades Primoris Services Corporation (PRIM) to Overweight